Information at a glance

• March 24-25, 2018; held immediately following the HOPA 14th Annual Conference
• Location: Colorado Convention Center in Denver, CO
• View Course announcement
• View the New Course Agenda with Speakers! 

This course is jointly planned by the American Society for Blood and Marrow Transplantation and the National Marrow Donor Program®/ Be The Match®.

Register Now

Event Registration

Details

The registration fee includes admission and access to PowerPoint slides from the Fundamentals of HCT Training Course along with continuing pharmacy education credits.

Participants are responsible for their own travel and hotel arrangements.

Registration for the Fundamentals of HCT Training Course is a
separate fee from the HOPA 14th Annual Conference.

The course book may be purchased as an addition to registration.

A free webinar entitled “Intro to HCT” will be available prior to the course; it is encouraged to view this material. This webinar, in addition to attending the Fundamentals course, can count towards the 10 hours related to cellular therapy that is required by FACT for BMT healthcare professionals.  The webinar will be posted on the ASBMT Pharmacy Education SIG webpage.

About the Course

This interactive case-based course provides practitioners with the skills required to care for patients undergoing hematopoietic cell transplantation (HCT), with a focus on pharmacotherapeutic management throughout the transplant process.

The target audience for this course includes pharmacists, pharmacy student and residents, physicians (including residents and hematology/oncology fellows), advanced practice providers and nurses.

Overall Conference Educational Objectives

After attending the 2018 Fundamentals of HCT Training Course, participants should be able to:

1. Review the advantages and disadvantages of available strategies for stem cell mobilization.
2. Recognize the pharmacologic properties and toxicity profiles of autologous hematopoietic cell transplantation (HCT) preparative regimens.
3. Outline the approximate timeline and management of peri-engraftment complications following autologous HCT.
4. Select management strategies for infectious complications following autologous HCT.
5. Recall the pharmacologic properties and toxicity profiles of allogeneic HCT preparative regimens.
6. Describe how population pharmacokinetic models are used to support busulfan therapeutic drug monitoring and achievement of desired outcomes in HCT patients receiving busulfan.
7. Define sinusoidal obstructive syndrome (SOS) and outline risk factors, prevention strategies, and treatment modalities for SOS.
8. Discuss patient-specific considerations for special populations undergoing autologous or allogeneic HCT.
9. Examine the pathophysiology of graft-versus-host disease (GVHD) and available prophylactic approaches to prevent GVHD.
10. Review treatment options for steroid-refractory GVHD in allogeneic HCT patients.
11. Recognize risk factors, diagnostic criteria, and appropriate treatment strategies associated with transplant-associated thrombotic microangiopathy (TA-TMA).
12. Select a prophylactic and treatment strategy for common viral infections in HCT patients.
13. Outline the incidence of invasive fungal infections in HCT patients and describe strategies for prophylaxis, empiric therapy, and treatment of documented fungal infections.
14. Describe risk factors, prevention strategies, treatment strategies, and common long-term complications of chronic GVHD.
15. Explain the rationale for immunizations in the HCT patient population and identify a post-HCT immunization program for HCT patients. 

Pharmacist Continuing Education Information

For more information regarding pharmacist continuing education, please click here.

Syntaxx Communications, Inc. is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Syntaxx Communications has assigned 9.00 contact hours (0.9 CEUs) of continuing pharmacy education credit for this knowledge- and application-based activity. This 2-day conference will incorporate 15 individual activity sessions that combined will fulfill the 9.00 hours of CE. The target audience for this accredited activity is pharmacists.

To receive continuing pharmacy education credit for the conference, participants must attend the sessions in their entirety and complete the associated program evaluation forms. Additionally, all US-based pharmacists must supply their National Association of Boards of Pharmacy (NABP) electronic Profile Identification (ePID) number and their birth month and day (MM/DD). No credit can or will be issued without this information. To acquire an NABP ePID, go to http://www.nabp.net and click on CPE Monitor.

This 2-day conference will be comprised of 15 individual sessions identified by 15 distinct Universal Activity Numbers (UANs) and are to be assigned.

Program Evaluation Forms

The program evaluation forms may be accessed and completed online. These forms will be sent to attendees via a link provided by the National Marrow Donor Program. All participants completing program evaluation forms will receive a certificate of attendance provided by the NMDP/Be The Match.

For problems or issues related to continuing pharmacy education, please contact Amber Lawson at Syntaxx Communications:

E-mail: alawson@syntaxxcomm.com

Phone: 678.740.3580

Mail: 305 W Country Dr, Johns Creek, GA 30097

Required Computer Hardware/Software

Registrants are encouraged to bring a computer and print the materials before arriving at the conference.

This course will use the program Poll Everywhere to conduct live polling. Download the Poll Everywhere app via your app store or use the web link provided to answer using your mobile device or laptop. 

Financial Support

This course is made possible through course registration fees and educational grants to be announced.